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Two Matters Arising articles in this issue challenge the conclusions of a previous Cell Stem Cell paper that
found extensive transcriptional differences between hESCs and hiPSCs. The original authors provide
a response and set in motion a discussion in the field about appropriate methods for microarray data
analysis.The decisive discovery that differentiated
cells can be reprogrammed into induced
pluripotent stem cells (iPSCs) has opened
new lines for intellectual inquiry and prom-
ising avenues for medical therapies.
However, many fundamental unresolved
issues remain, such as what is the extent
of the pluripotency of iPSCs. The pluripo-
tency of many mouse iPSC lines has been
brought into question, because they have
attained some but not all of the diagnostic
hallmarks of pluripotency; for example,
many lines uniformly express pluripo-
tency markers and can activate an
Oct4-GFP reporter, but most lines are
incapable of tetraploid complementation,
which is the defining capability of a bona
fide pluripotent stem cell line (Stadtfeld
et al., 2010; Zhao et al., 2009). Thus,
current methods of transcription factor-
mediated reprogramming fail to fully
recreate authentic embryonic pluripo-
tency in the majority of differentiated
mouse cells (Figure 1). A Matters Arising
discussion in this issue of Cell Stem Cell
addresses the extent of pluripotency of
human iPSCs, a topic that has substantial
implications for the use of human iPSCs in
the laboratory and the clinic.
Are human iPSCs an exact reproduc-
tion of human embryonic stem cells
(ESCs), or have they inherited the incom-
plete pluripotency of their mouse iPSC
counterparts? It is currently not possible
to use embryo complementation-based
measures to assess the pluripotency of
human iPSCs, so instead Chin and
colleagues conducted a transcriptional
comparison of five human iPSC lines
and three human ESC lines to determine
how closely human iPSCs resemble
ESCs (Chin et al., 2009). They found that
318 genes and 16 microRNAs wereconsistently differentially expressed
between iPSC and ESC lines, and, based
on these results, concluded that the
induced pluripotency of human iPSC
lines is transcriptionally distinct from the
embryonic pluripotency of human ESC
lines.
In this issue of Cell Stem Cell, Guenther
and colleagues have revisited this topic,
employing statistical algorithms and cell
lines different from those used by Chin
and colleagues (Guenther et al., 2010).
After rigorous transcriptional comparison
of six human iPSC lines and six human
ESC lines, Guenther et al. concluded that
only four genes are consistently differen-
tially expressed between human iPSCs
and ESCs. They also did not find signifi-
cant differences between the genome-
wide distributions of the activating
H3K4me3 and repressive H3K27me3 his-
tone modifications in human iPSCs and
ESCs, consistent with results obtained
by Chin et al. (2009). Based on their anal-
yses, Guenther et al. (2010) assert that
human iPSCs have accurately reinstalled
the transcriptional and epigenetic controls
of ESCs and that there are minimal overt
molecular differences between human
iPSCs and ESCs.
In a separate study, Newman and
Cooper conducted a microarray compar-
ison of 17 human ESC lines and 67 human
iPSC lines that were produced in 7 inde-
pendent laboratories (Newman and
Cooper, 2010). After unsupervised tran-
scriptome clustering, they do not find
that human iPSCs segregate into one
distinct cluster and that human ESCs
segregate into their own cluster, as would
be expected if there were consistent tran-
scriptional differences between human
iPSCs and ESCs. Instead, they find thatCell Stem Celhuman iPSC and ESC lines cultured in
the same laboratory reproducibly cluster
together. This suggests that each unique
laboratory’s culture condition imposes
a distinct transcriptional footprint in cell
lines cultured within it, and that these
laboratory-specific transcriptional signa-
tures overshadow any possible transcrip-
tional differences between human iPSCs
and ESCs.
What could be the cause for the
considerable discrepancies between the
results reported by these three groups?
In their response, Chin et al. (2010)
discuss the statistical practices that
they used in analyzing their microarray
data and deliberate on the differences
between their algorithms and those em-
ployed by Guenther et al. (2010) and
Newman and Cooper (2010). Chin et al.
(2010) also point out that they designed
part of their analysis to be intralaboratory
comparisons to control for the interlabor-
atory differences highlighted by Newman
and Cooper (2010). At a broader level,
Chin et al. (2010) challenge members of
the field to unite and to develop stan-
dardized best practices for microarray
data analysis. We agree that adoption
of standard practices would be an
advance for the field overall and would
help ensure that different groups do not
come to different conclusions when an-
alyzing the same data set. Finally, Chin
et al. (2010) remind us that the lineage
and genetic background of the starting
cell type as well as the type of reprog-
ramming vector used (integrating or non-
integrating) will significantly impact the
properties of the resulting iPSCs (Stadt-
feld et al., 2010).
This discussion elicited by Chin et al.
(2010) also brings up broader questionsl 7, August 6, 2010 ª2010 Elsevier Inc. 137
Figure 1. Recreating Pluripotency in Differentiated Human and Mouse Cells
Transcription factor-induced reprogramming in mouse cells frequently fails to recreate authentic embryonic pluripotency. This diagram defines an operational
continuum of stable cell lines that arise after overexpression of the reprogramming factors—‘‘fully reprogrammed’’ mouse iPSC lines (rare), ‘‘mostly reprog-
rammed’’ mouse iPSC lines, and ‘‘poorly reprogrammed’’ nullipotent cell lines. A critical question for human cells is whether human iPSC lines correspond to
the ‘‘mostly reprogrammed’’ or ‘‘fully reprogrammed’’ iPSC lines present in the mouse system. The Matters Arising articles in this issue, and the original paper
to which they refer, help address this question. N.D., not determined.
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determine whether or not a cell type is
pluripotent. Is transcriptional similarity to
embryonic pluripotency even pertinent
when we are attempting to ascertain the
pluripotency of iPSCs? In the mouse,
there are several transcriptional programs
that can produce a pluripotent cell, as
shown by the fact that mouse ESCs,
mouse embryonic germ cells, and mouse
epiblast stem cells—which are all pluripo-
tent stem cells—are all transcriptionally
different from one another (Sharova
et al., 2007; Tesar et al., 2007). The idea
that there are many (transcriptional) roads
to pluripotency could suggest that minor
transcriptional or epigenetic differences
between ESCs and iPSCs might be func-
tionally inconsequential to the pluripo-
tency of iPSCs.
However, an important study argues
otherwise, by showing that differential
expression of even a few genes between
mouse iPSCs and ESCs can compromise
the pluripotency of mouse iPSC lines
(Stadtfeld et al., 2010). They found that
most established mouse iPSC lines
(95%) have downregulated several
genes from the Gtl2 locus relative to
ESCs. These cell lines uniformly express138 Cell Stem Cell 7, August 6, 2010 ª2010 Epluripotency markers and activate an
Oct4-GFP reporter, but are consistently
incapable of tetraploid complementation
resulting from their repression of the Gtl2
locus (Stadtfeld et al., 2010). We refer to
these cell lines—the majority of mouse
iPSC lines—as ‘‘mostly reprogrammed,’’
despite their acquisition of many pluripo-
tent hallmarks (Figure 1). They are distinct
from previously described dedifferenti-
ated ‘‘poorly reprogrammed’’ intermedi-
ates that express few pluripotency
markers and fail to activate an Oct4-GFP
reporter, but which can be coerced into
a fully reprogrammed state (Figure 1; Mik-
kelsen et al., 2008).
These striking observations raise the
question of whether it is even possible
to recreate authentic embryonic pluripo-
tency in differentiated cells by the intro-
duction of defined factors. We remain
confident that it is possible. Rare mouse
iPSC lines (5%) have correctly upregu-
lated expression of genes in the Gtl2
locus and we call them ‘‘fully reprog-
rammed,’’ because they are capable of
tetraploid complementation, and thus,
they have recreated authentic embryonic
pluripotency (Stadtfeld et al., 2010).
Given that gene expression is a functionlsevier Inc.of the transcription factors and epige-
netic regulators in the nucleus (Yama-
naka and Blau, 2010), it seems logical
that it should be possible to recreate
genuine pluripotency in iPSCs by intro-
ducing all the critical nuclear regulators
that are present in ESCs into differenti-
ated cells. Thus, our current inability to
efficiently generate mouse iPSC lines
capable of tetraploid complementation
must reflect that our current reprogram-
ming factors are an incomplete represen-
tation of the necessary critical regulators.
To this end, we note that the transcription
factor Tbx3 can increase the germline
transmission potential of mouse iPSCs
when it is overexpressed during the re-
programming process (Han et al., 2010).
It is likely that additional factors with
similar effects will be found in the near
future, thus allowing for the efficient
recreation of authentic embryonic pluri-
potency in differentiated cells.
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Recent publications by Kim et al. (Kim, K., Doi,
A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim,
J., Aryee, M.J., Ji, H., Ehrlich, L.I., et al.
(2010). Nature, in press. Published online JulyCell Stem Cel19, 2010. 10.1038/nature09342) and Polo et al.
(Polo, J.M., Liu, S., Figueroa, M.E., Kulalert,
W., Eminli, S., Tan, K.Y., Apostolou, E., Stadt-
feld, M., Li, Y., Shioda, T. et al. (2010). Nat. Bio-
technol., in press. Published online July 19,
2010. 10.1038/nbt.1667) extend on the publica-
tions previewed here. In brief, Kim et al. and
Polo et al. show that mouse iPSCs derived
from distinct differentiated cell types show
defining transcriptional and epigenetic similari-
ties with their starting cell of origin. This reten-
tion of the starting cell’s transcriptional program
in iPSCs could explain why certain genes are
differentially expressed between human iPSCs
and ESCs, as discussed here. Furthermore,
Polo et al. show that after extended passaging,
mouse iPSCs largely censor these cell-of-
origin-specific transcriptional programs, thus af-
firming Chin et al. (2009)’s findings that
extended passaging of human iPSC lines
increases their transcriptional similarity to human
ESC lines.Getting to the Heart of the Matter:
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Since MyoD was used to convert fibroblasts directly to skeletal muscle, biologists have tried to apply this
strategy to generate other cell lineages. In their recentCell paper, Ieda et al. (2010) use selected cardiac tran-
scription factors to directly reprogram fibroblasts to cardiomyocytes without passing through an intervening
pluripotent state.A landmark paper from Takahashi and
Yamanaka (2006) showed that adult
mammalian cells could be reverted to
a pluripotent state with just four transcrip-
tion factors. Before that time, pluripotent
cell reprogramming was thought to re-
quire either somatic cell nuclear transfer
into an unfertilized egg cell or fusion of
somatic cells with pluripotent embryonic
stem cells (ESCs) (Hochedlinger and
Jaenisch, 2006). Direct reprogramming
of terminally differentiated cells, also
called lineage reprogramming, had been
limited to skeletal muscle via MyoD. This
transcription factor became recognized
as a ‘‘master regulator gene,’’ because
it was able to convert fibroblasts, chon-
drocytes, and retinal epithelium into con-
tracting muscle in culture (Choi et al.,1990). Subsequent examples included
the conversion of B lymphocytes into
macrophages by CEP/B (Xie et al., 2004)
and inner ear support cells into sensory
hair cells by Math1 (Izumikawa et al.,
2005). Yet, despite years of research,
master regulators for other lineages have
remained elusive. Now, with an approach
similar to Yamanaka’s, Srivistava and
colleagues demonstrate that fully func-
tional cardiomyocytes can be derived
from cardiac and skin fibroblasts (Ieda
et al., 2010).
Master Regulators: A Team
Approach
Yamanaka demonstrated that a selected
group of transcription factors was suffi-
cient to direct somatic cells to adoptan immature pluripotent state and that
this conversion involved the loss of
the original imprint that determined the
cells’ functional characteristics. This find-
ing helped shift the field’s approach to
lineage reprogramming. Instead of per-
forming modest searches for single mas-
ter regulator genes, hundreds of critical
developmental factors were screened
in multiple combinations with lineage
reporter cells as readouts. Yamanaka’s
protocol reduced several hundred pluri-
potency candidate genes to just four.
Why not try the same direct reprogram-
ming paradigm to generate specific differ-
entiated cell lineages?
Melton and colleagues applied this
technique successfully to identify a
small set of genes capable of convertingl 7, August 6, 2010 ª2010 Elsevier Inc. 139
